Stay updated with breaking news from Essential Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UK marketing authorisations for IOPIDINE (apraclonidine) fully transferred to Essential Pharma as change in UK NICE guidelines for glaucoma treatment expected to lead to increase in patients' need
Essential Pharma Announces the Acquisition of HALDOL HALDOL is a first-generation 'typical' antipsychotic for the treatment of schizophrenia and some other psychiatric conditions The acquisition
This article reviews the application of competition law principles to the pharmaceutical sector in United Kingdom, with particular regard to the merger control regime and anticompetitive behaviour.
Essential Pharma, an international speciality pharma group focused on maintaining access to well-established, “at risk” products essential to patients across multiple therapeutic areas, announces the strengthening of its operating platform to support the next phase of its growth, with the granting of new ...
EGHAM, England, Aug. 25, 2022 /PRNewswire/ -- Essential Pharma, an international speciality pharma group focused on maintaining access to well-established, "at risk" products essential to patients